Portal de datos abiertos de la Unión Europea - Custom query: Cobertura geográfica filters: Greece; Temas filters: Población y sociedadtag:data.europa.eu,2012:/feeds/custom.atom?vocab_geographical_coverage=http%3A%2F%2Fpublications.europa.eu%2Fresource%2Fauthority%2Fcountry%2FGRC&vocab_theme=http%3A%2F%2Fpublications.europa.eu%2Fresource%2Fauthority%2Fdata-theme%2FSOCI2024-03-20T14:56:13ZEuropean Publications Officehttps://data.europa.eu/euodpRecently created or updated datasets on Portal de datos abiertos de la Unión Europea. Custom query: Cobertura geográfica filters: Greece; Temas filters: Población y sociedadDrugs in municipal wastewater in selected European and international citiestag:data.europa.eu,2012:/dataset/drugs-in-municipal-wastewater-in-selected-european-citiesAnalysing communal wastewaters for drugs and their metabolic products in order to estimate their consumption in the community is a developing field, involving scientists working in different research areas, including analytical chemistry, physiology and biochemistry, sewage engineering, spatial epidemiology and statistics, and conventional drug epidemiology. This data is collected by scientitistand experts in a Europe-wide network (Sewage analysis CORe group — Europe (SCORE)). Data from a range of cities is available and has been collected since 2011.2024-03-20T14:56:13Z2021-07-12T17:30:45ZSource data for EU Drug Market: Heroin and other opioids — In-depth analysistag:data.europa.eu,2012:/dataset/source-data-for-eu-drug-market-heroin-and-other-opioids-in-depth-analysisEU Drug Market: Heroin and other opioids describes the European opioids market from production and trafficking to distribution and use. It details the processes, materials and players involved at various stages and levels of the market. This dataset contains most the source data behind the graphics used in the report as well as additional data tables. 2024-01-24T12:21:03Z2024-01-24T12:15:13ZFrequently asked questions (FAQ): drug overdose deaths in Europetag:data.europa.eu,2012:/dataset/frequently-asked-questions-faq-drug-overdose-deaths-in-europeThis data bundle contains all source data for graphics and visualisation used on the page, Frequently asked questions (FAQ): drug overdose deaths in Europe.. It includes the following tables.
Table A. Year of most recent overdose data
Table 1. Drug-induced deaths in the European Union, Norway and Türkiye: total number among adults aged 15-64 years if available, otherwise all ages, 2021
Table 2. Drug-induced mortality rates per million among adults (15-64): selected trends
Table 3. Drug-induced mortality rates per million among adults (15-64)
Table 4. Proportion of males among drug-related deaths in the European Union, Norway and Türkiye, 2021
Table 5. Distribution of drug-induced deaths reported in 2012 and in 2020, or most recent
Table 6. Distribution of drug-induced deaths reported in 2021, or most recent year, by age group and by country
Table 7. Proportion of drug-induced deaths among older (40+ years) people in the European Union, Norway and Türkiye, 2020 (or most recent data available)
Table 8. Proportion of drug-induced deaths among older (40+ years) people in the European Union, Norway and Türkiye, 2021 (or most recent data available)
Table 9. Proportion of drug-induced deaths with opioids involved in the European Union, Norway and Türkiye, 2020 (or most recent data available)
Table 10. Indexed trends in the number of deaths in selected countries in the south east of Europe, 2011-2020 (2011 = 100)
Table 11. Indexed trends in the number of deaths in selected countries in the north of Europe, 2011-2020 (2011 = 100)
Table 12. Sources used by the countries to report drug-induced deaths to the EMCDDA, 2020 (or most recent data available)
Table 13. Sources preferred by the countries to report drug-induced deaths to the EMCDDA, 2020 (or most recent data available)
Table 14. Mortality cohort studies among people using drugs in Europe: countries with studies conducted within the last 10 years or earlier. June 2021 – provisional findings
Table 15. Countries included in the ‘southeast’ and ‘north’ of Europe for this trend analysis
Table 16. Number of European countries implementing harm reduction interventions, up to 20222023-10-06T12:15:18Z2023-09-19T13:42:56ZErasmus mobility statistics 2014 - 2020tag:data.europa.eu,2012:/dataset/erasmus-mobility-statistics-2014-2020This dataset contains the raw data for Erasmus+ mobility for students (study exchanges and work placements) and staff (teaching assignments and staff training) in 2014-2020. The data contains information on various fields: age, gender, duration, special needs, subject area, level of study, sending and receiving country, etc. 2023-09-18T15:25:36Z2023-05-07T07:53:59ZEuropean Drug Report 2023 — all source datatag:data.europa.eu,2012:/dataset/european-drug-report-2023-all-source-dataThe European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm reduction interventions.
This data set contains all off the source data used to generate graphics and data visualisations for the report and covers a broad range of drug-related topics in the EU, Norway and Türkiye2023-09-15T13:00:39Z2023-08-31T14:51:31ZDrug-induced deaths in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/drug-induced-deaths-in-europe-emcdda-2023-statistical-bulletinDrug-related mortality is a complex phenomenon, which accounts for a considerable percentage of deaths among young people in many European countries. The EMCDDA, in collaboration with national experts, has defined an epidemiological indicator with two components at present: deaths directly caused by illegal drugs (drug-induced deaths) and mortality rates among problem drug users. These two components can fulfil several public health objectives, notably as an indicator of the overall health impact of drug use and the components of this impact, identify particularly risky patterns of use, and potentially identify new risks.
There are around **50 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2023-08-11T18:20:35Z2023-08-11T18:17:12ZDrug-related infectious diseases in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/drug-related-infectious-diseases-in-europe-emcdda-2023-statistical-bulletinDrug-related infectious diseases such as HIV and hepatitis B and C are among the most serious health consequences of drug use. Even in countries where HIV prevalence in injecting drug users (IDUs) is low, other infectious diseases, such as hepatitis B/C, sexually transmitted diseases, TB, anthrax, tetanus, botulism, hepatitis A, HTLV may disproportionately affect drug users.
There are about **25 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2023-08-11T18:12:07Z2023-08-11T18:09:16ZDrug law offences in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/drug-law-offences-in-europe-emcdda-2023-statistical-bulletinReports of offences against national drug legislation (use, possession, trafficking, etc.) reflect differences in law but also the different ways in which the law is enforced and applied, and the priorities and resources allocated to specific problems by criminal justice agencies. In addition, information systems on drug law offences/offenders vary considerably between countries, especially as regards recording procedures, definitions and statistical units.
There are around **30 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2023-08-11T18:05:10Z2023-08-11T18:04:19ZHealth and social responses to drug problems in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/health-and-social-responses-to-drug-problems-in-europe-emcdda-2023-statistical-bulletinHealth and social responses data reported here comprises information on the availability of different types of needle and syringe programmes (NSPs) in the country, including prison-, pharmacy- and non pharmacy-based programmes and on the number of syringes provided at these programmes.
2023-08-11T17:59:30Z2023-08-11T17:59:30ZDrug seizures in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/drug-seizures-in-europe-emcdda-2023-statistical-bulletinData on drug seizures relate to all seizures made in each country during the year by all law enforcement agencies (police, customs, national guard, etc.). Caution is required in relation to double-counting that might occur within a country — although it is usually avoided — between various law enforcement agencies.
2023-08-11T17:53:58Z2023-08-11T17:50:21ZProblem drug use in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/2ff6ad28-019a-465a-986d-d59d2c88cda6‘Problem drug use’ is defined by the EMCDDA as ‘injecting drug use or long duration / regular use of opioids, cocaine and/or amphetamines’. This definition specifically includes regular or long-term use of prescribed opioids such as methadone but does not include their rare or irregular use nor the use of other drugs, such as ecstasy or cannabis. Existing estimates of problem drug use are often limited to opioid and poly-drug use.
There are approximately **20 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (XLS/Excel format).2023-08-11T17:42:56Z2023-08-11T17:30:26ZPrice, purity and potency of drugs in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/price-purity-and-potency-of-drugs-in-europe-emcdda-2023-statistical-bulletinStreet prices of cannabis, heroin, cocaine and amphetamine are provided in euros per gram, of LSD in euros per unit/dose, and of ecstasy in euros per tablet. Data on prices come from a range of different sources, the comparability of which is not always known. Data on the potency of cannabis products and the purity of heroin (white and brown), cocaine products (cocaine and crack) and amphetamine are presented here. In addition, data on the MDMA content (weight in ecstasy tablets) is provided.
There are over **100 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2023-08-11T17:24:46Z2023-08-11T16:49:09ZDrug treatment demand in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/drug-treatment-demand-in-europe-emcdda-2023-statistical-bulletin-duplicatedInformation on the number of people entering treatment for a drug problem provides insight into general trends in problem drug use and also offers a perspective on the organisation and uptake of treatment facilities. ‘Treatment demand data’ come from each country with varying degrees of national coverage, principally from outpatient and inpatient centres’ treatment records.
There are over **300 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2023-08-11T17:18:22Z2023-08-11T16:34:40ZPrevalence of drug use in Europe (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/prevalence-of-drug-use-in-europe-emcdda-2023-statistical-bulletinPrevalence and patterns of drug use in the general population (adults or school children) is assessed through surveys based on representative probabilistic samples of the whole population under study. Interview surveys are based on self-report of participants regarding present and past behaviours, personal characteristics, knowledge and attitudes regarding drugs or other health topics.
There are over **300 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2023-08-11T17:01:30Z2023-08-11T16:47:30ZDrugs and prison (EMCDDA 2023 Statistical Bulletin)EMCDDAinfo@emcdda.europa.eutag:data.europa.eu,2012:/dataset/drugs-and-prison-emcdda-2023-statistical-bulletin-duplicatedNational routine information on drug use and patterns of use amongst prisoners is rare. Most of the data available in the EU come from ad-hoc studies amongst prisoners, carried out at local level, with samples that vary considerably in size and which are often not representative of the whole prison system. This makes extrapolation to a national figure for the prison system very difficult. Furthermore, the lack of repeated surveys impedes trend analysis in most of the EU countries.
There are over **300 statistical tables** in this dataset. Each data table may be viewed as an HTML table or downloaded in spreadsheet (Excel format).2023-08-11T16:44:17Z2023-08-11T16:39:17ZErasmus mobility statistics 2021European Commission Directorate General Education and Culturetag:data.europa.eu,2012:/dataset/erasmus-mobility-statistics-2021This dataset contains the raw data for Erasmus+ mobility for students (study exchanges and work placements) and staff (teaching assignments and staff training) in 2021. The data contains information on various fields: age, gender, duration, special needs, subject area, level of study, sending and receiving country, etc.2023-07-17T14:58:13Z2023-04-19T10:28:09ZJRC Mobility Functional Areas estimatesEuropean Commission, Joint Research Centre (JRC)mailto:stefano.iacus@ec.europa.eutag:data.europa.eu,2012:/dataset/7fcb757f-51d9-49a5-91e0-7477ed80f7e9The dataset contains information about how subnational geographical areas cluster with in terms of human mobility measured through Mobile Network Operator (MNO) data, irrespective of the administrative borders.
A Mobility Functional Area (MFA) is a dense cluster of highly interconnected regions.
For each geographical area, the data consists of an id, the id of the MFA to which the area belongs, the type of MFA, the country and the NUTS3 reference, and the id of the MNO operator (there might be multiple operators per country). The definition of the geographical area change from country to country and varies from census level (ACE), LAU, or other aggregation defined by the corresponing MNO.
The shape files are available separately. https://migration-demography-tools.jrc.ec.europa.eu/static/Data/mfa-shapefiles.zip
Read more about the European Commission Data4Covid Initiative at EU Science Hub (https://ec.europa.eu/jrc/en/news/coronavirus-mobility-data-provides-insights-virus-spread-and-containment-help-inform-future) and at GSMA Europe (https://www.gsma.com/gsmaeurope/resources/d4c/)2023-05-03T16:20:59Z2022-05-23T23:50:52ZAgeing Report 2021Directorate-General for Economic and Financial Affairs - Unit C2 - Sustainability of public financesECFIN-Secretariat-C2@ec.europa.eutag:data.europa.eu,2012:/dataset/ageing-report-2018Long-term projections of the budgetary impact of the ageing population in the EU Member States and Norway, covering the period 2019–2070.
The Statistical Annexes give an overview of the main assumptions and macroeconomic projections as well as projection results of age-related expenditure items by area and by country. 2023-02-20T14:33:05Z2019-09-20T16:03:00ZGender Equality IndexEuropean Institute for Gender Equalityeige.sec@eige.europa.eutag:data.europa.eu,2012:/dataset/gender-equality-indexThe Gender Equality Index is a tool to measure the progress of gender equality in the EU, developed by EIGE. It gives more visibility to areas that need improvement and ultimately supports policy makers to design more effective gender equality measures.
The Gender Equality Index has tracked the painfully slow progress of gender equality in the EU since 2010, mostly due to advances in decision-making. While equality is more pronounced in some Member States than in others, it is far from a reality for everyone in every area. Gender norms around care, gender segregation in education and the labour market, and gender inequalities in pay remain pertinent.
The Index allows Member States to easily monitor and compare gender equality progress across various groups of women and men in the EU over time and to understand where improvements are most needed. The 2022 Index has a thematic focus on care in the Covid-19 pandemic. It explores the division of informal childcare, long-term care and housework between women and men.
The Gender Equality Index is a composite indicator. With a total of six core domains (work, money, knowledge, time, power and health) and two satellite domains (violence against women and intersecting inequalities), it offers a synthetic and easy-to-interpret measure for gender equality, indicating how far (or close) the EU and its Member States are from achieving gender equality on a scale of 1 to 100.
Building on previous editions alongside EIGE’s approach to ensuring intersecting inequalities are captured, the Gender Equality Index 2022 continues to show the diverse realities that different groups of women and men face. It examines how elements such as disability, age, level of education, country of birth and family type can intersect with gender and create many different kinds of pathways in people's lives.
2023-02-01T13:48:02Z2015-07-27T15:05:48ZElection data by local/regional constituencies 2013-2018regio-b1-papers@ec.europa.eutag:data.europa.eu,2012:/dataset/election-data-by-local-regional-constituencies-2013-2018This dataset contains the results of national elections across more than 63000 electoral districts and local administrative areas in the EU-28 Member States. The dataset has been analysed in the working paper "The geography of EU discontent".2023-01-13T10:19:43Z2019-11-20T15:47:39Z